Astria Therapeutics
ATXS
ATXS
27 hedge funds and large institutions have $24.9M invested in Astria Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $31.3M → $24.9M (-$6.35M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
27
Holding in Top 10
1
Calls
$4.67M
Puts
–
Top Buyers
| 1 | +$3.84M | |
| 2 | +$1.05M | |
| 3 | +$674K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$645K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$228K |
Top Sellers
| 1 | -$3.65M | |
| 2 | -$578K | |
| 3 | -$494K | |
| 4 |
PTP
Platform Technology Partners
New York
|
-$195K |
| 5 |
JPMorgan Chase & Co
New York
|
-$167K |